Monthly focus

Catching up with CRISPR

06 December 2019

CRISPR-Cas9 is a versatile gene editing system that exploits the way that bacterial immune systems defend against viruses. Image credit - Flickr/ NIH Image Gallery, image is in the public domain

Seven years after scientists successfully managed to adapt a gene editing system used by bacteria into one that can be easily used in labs to edit human genes, we take a look at some of the emerging applications and ethical issues of CRISPR-Cas9. We talk to the head of the European Group on Ethics in Science and New Technologies about whether the simplicity and low cost of CRISPR means that there is potential for misuse and what should be done about this. We find out how scientists have used CRISPR to create cows lacking two sugars that trigger the human immune system, leading to hopes of longer-lasting heart valves for transplant patients and healthier red meat. And we speak to researchers who are using CRISPR to improve other gene editing technologies.

Gene editing researchers should act responsibly and not be driven by fame or patents, says Prof. Christiane Woopen. Image credit - Reiner Zensen

interview | health

17 December 2019

We need to talk about CRISPR

We need an active public debate on the ethics of gene editing technology to realise its potential and prevent it being used in nefarious ways, for example by the military and amateur scientists, and to take cultural differences into account, according to Professor Christiane Woopen, executive director of the Centre for Ethics, Rights, Economics and Social Sciences of Health (CERES) at Germany’s University of Cologne.

In sickle cell disease, the red blood cells are misshapen and don't carry oxygen well. Image credit - OpenStax College licensed under CC BY 3.0

health

12 December 2019

CRISPR provides hope of sickle cell cure

Thanks to the ‘cut and paste’ gene editing technique CRISPR, scientists are homing in on a cure for sickle cell disease - a genetic blood disorder - while other research is looking at how to expand the potential of CRISPR-based treatments.

Genetically engineered mutations in cows could pave the way for transplant patients to receive whole animal organs in the future. Image credit - Pexels/Kat Jayne, licensed under Pexels license

health

06 December 2019

Genetically engineered animals offer fresh hope to heart valve patients

Scientists have cloned a genetically engineered bull which they hope will help heart valve transplant patients lead better quality lives and benefit people with red meat allergies.

Recommended for you

How can we predict, detect and tackle future outbreaks of emerging diseases? Image credit - Unsplash/Tedward Quinn

Coronavirus and beyond: emerging disease outbreaks

With the world in the grip of the coronavirus pandemic, in April Horizon takes a step back to look at some of the challenges around sudden outbreaks of emerging diseases. We speak to virologist Prof. Marion Koopmans about the likelihood of future outbreaks of new diseases, what causes them and how to spot them before they appear. We speak to scientists who are helping to develop tests for Covid-19 to understand the challenges in coming up with an accurate and detailed diagnostic test for an entirely new disease. We talk to people working on coronavirus treatments about how to shorten the normally lengthy process of drug development. And we look into why diseases suddenly jump from animals, such as bats, into humans and the particular challenges of spotting and responding to these types of outbreaks.

The rise of private companies in the space industry is creating both opportunities and challenges. Image credit - Flickr/SpaceX, licenced under CC BY-NC 2.0

The business of space

Private companies are increasingly active in the space sector – from high-profile businesses such as SpaceX or Virgin Galactic to the nearly 3,000 small businesses that provide elements for the European Space Agency’s space programme. In March, Horizon explores the impact of this on research and innovation. We speak to a space law researcher about how to avoid the problems emerging from an increasingly crowded orbit, such as collisions. We look at how to minimise the environmental impact of satellites and delve into efforts to build a reusable European launcher for small payloads. We also look at the challenge of assembling, maintaining and repairing objects in space and the developments in space robotics that could help.

Scientists hope a new pipeline will be able to churn out remedies for any newly emerging virus. Image credit - Unsplash/ Maksym Kaharlytskyi, licenced under CC0

Studying animal coronavirus defences is opening route to human treatments

A team that has spent the last five years developing a pipeline of technologies that can churn out a remedy for almost any newly emerging virus may have treatments ready for safety trials on Covid-19 patients by the end of the year.

Skypull's prototype designs are being tested in Switzerland to prove that the concept works before they build a full-size version. Image credit - Skypull

Flying high: how drones on cables are expanding the scope of wind energy

By harnessing the power of strong winds at higher altitude than turbines reach, airborne wind energy could be another key source of renewable energy, but it will need a combination of successful designs, more robust software and good storytelling to really take off.

Catching up with CRISPR